CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+4.75%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.32B
AUM Growth
+$5.32B
(+3%)
Cap. Flow
-$29.2M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
16.3%
Holding
745
New
50
Increased
313
Reduced
250
Closed
35
Top Buys
| 1 |
Kellanova
K
|
$30.1M |
| 2 |
Colgate-Palmolive
CL
|
$20M |
| 3 |
Corning
GLW
|
$19.4M |
| 4 |
Merck
MRK
|
$18.9M |
| 5 |
SPLS
Staples Inc
SPLS
|
$18M |
Top Sells
| 1 |
PepsiCo
PEP
|
$40.6M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$37.8M |
| 3 |
Meta Platforms (Facebook)
META
|
$23.6M |
| 4 |
Oracle
ORCL
|
$22.4M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$21.2M |
Sector Composition
| 1 | Healthcare | 25.58% |
| 2 | Technology | 13.64% |
| 3 | Financials | 13.2% |
| 4 | Consumer Discretionary | 9.51% |
| 5 | Communication Services | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$3.45T
| $110M | 2.07% | 763,222 -25,372 | -3% | -$3.65M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $108M | 2.02% | 829,286 +96,167 | +13% | +$12.5M |
|
3
Amgen
AMGN
$155B
| $102M | 1.92% | 591,743 +63,181 | +12% | +$10.9M |
|
4
Gilead Sciences
GILD
$140B
| $101M | 1.9% | 1,426,061 -92,507 | -6% | -$6.55M |
|
|
5
Alphabet (Google) Class A
GOOGL
$2.57T
| $82.8M | 1.56% | 89,084 -40,652 | -31% | -$37.8M |
|
6
Amazon
AMZN
$2.44T
| $81.8M | 1.54% | 84,512 -379 | -0.4% | -$367K |
|
7
Exxon Mobil
XOM
$487B
| $81M | 1.52% | 1,002,920 +58,732 | +6% | +$4.74M |
|
8
Microsoft
MSFT
$3.77T
| $70.4M | 1.32% | 1,021,550 -17,633 | -2% | -$1.22M |
|
9
Johnson & Johnson
JNJ
$427B
| $67.3M | 1.26% | 508,618 -10,186 | -2% | -$1.35M |
|
10
GE Aerospace
GE
$292B
| $63.4M | 1.19% | 2,348,396 +196,900 | +9% | +$5.32M |
|
|
11
Regeneron Pharmaceuticals
REGN
$61.5B
| $62.6M | 1.18% | 127,543 -43,180 | -25% | -$21.2M |
|
|
12
Meta Platforms (Facebook)
META
$1.86T
| $60M | 1.13% | 397,230 -156,191 | -28% | -$23.6M |
|
13
Biogen
BIIB
$19.4B
| $59.6M | 1.12% | 219,601 +44,643 | +26% | +$12.1M |
|
14
Alibaba
BABA
$322B
| $57M | 1.07% | 404,418 +72,980 | +22% | +$10.3M |
|
15
JPMorgan Chase
JPM
$829B
| $50.9M | 0.96% | 557,210 +28,657 | +5% | +$2.62M |
|
|
16
Colgate-Palmolive
CL
$67.9B
| $45.7M | 0.86% | 616,886 +269,381 | +78% | +$20M |
|
17
Incyte
INCY
$16.5B
| $44.9M | 0.84% | 356,744 +14,388 | +4% | +$1.81M |
|
18
AT&T
T
$209B
| $43.9M | 0.83% | 1,163,541 -31,025 | -3% | -$1.17M |
|
19
Microchip Technology
MCHP
$35.1B
| $41.3M | 0.78% | 535,017 +71,848 | +16% | +$5.55M |
|
|
20
Kellanova
K
$27.6B
| $39.5M | 0.74% | 568,062 +432,833 | +320% | +$30.1M |
|
|
21
Merck
MRK
$210B
| $38.9M | 0.73% | 606,910 +295,293 | +95% | +$18.9M |
|
22
UnitedHealth
UNH
$281B
| $37.3M | 0.7% | 201,172 +32,800 | +19% | +$6.08M |
|
23
Verizon
VZ
$186B
| $36.6M | 0.69% | 819,186 -10,350 | -1% | -$462K |
|
24
Campbell Soup
CPB
$9.52B
| $36M | 0.68% | 689,378 +195,795 | +40% | +$10.2M |
|
25
Vertex Pharmaceuticals
VRTX
$100B
| $35.2M | 0.66% | 273,420 +40,853 | +18% | +$5.26M |
|